The prosthetic joint infection market has been growing rapidly owing to the increasing number of joint replacement surgeries performed globally each year. Prosthetic joint infections occur when bacteria or other microbes enter the surgical site during or after a hip or knee replacement surgery. The implants used for joint replacements, such as knees, hips, and shoulders, can get infected by some types of bacteria. Symptoms of prosthetic joint infection include pain, swelling, drainage, redness or warmth around the area of the joint replacement. There is an increasing need for effective treatment options and prevention measures for prosthetic joint infections, as these can cause pain, loss of mobility and may even require another surgery for implant removal and antibiotic treatment if not addressed promptly. The Global Prosthetic Joint Infection Market is estimated to be valued at US$ 64.2 Million in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the prosthetic joint infection market are Zimmer Biomet, Smith & Nephew, DePuy Synthes (Johnson & Johnson), Stryker, 3M Healthcare. Zimmer Biomet and Stryker collectively hold over 45% of the market share owing to their wide product portfolios and global presence.

Some key opportunities in the market include expanding into developing countries, launch of advanced diagnostic tests with short turn-around-times and development of novel antibiofilm coatings for implants. The increasing implantation volumes in Asia Pacific and Latin American countries will drive significant growth.

Globally, the incidence of prosthetic joint infections is expected to double by 2030 owing to rising geriatric population globally. Key players are expanding their presence in Asia Pacific and Latin American countries to gain early mover advantages. Partnerships with local distributors are helping penetrated untapped markets.

Market Drivers
Rising geriatric population worldwide susceptible to osteoarthritis and other joint conditions driving joint replacement volumes. According to the UN, over next 30 years 2000 Mn people will be aged over 60 worldwide creating high demand.

Market Restrains
High cost of treatment for prosthetic joint infections adds a significant burden on joint replacement patients and healthcare systems. PJI treatment often requires a two-stage process of implant removal followed by antibiotic treatment and new implantation which is very expensive.

Segment Analysis
The prosthetic joint infection market is dominated by the hip and knee implant sub-segment. Hip and knee replacement surgeries are commonly performed orthopedic procedures globally due to degenerative joint diseases like osteoarthritis and trauma or injury related joint damages. According to the Centers for Disease Control and Prevention (CDC), more than 7 million Americans have received hip or knee replacements. The increasing volume of such joint replacement surgeries directly translates to higher incidence of post-surgical prosthetic joint infections. Hence, the hip and knee implant sub-segment accounts for a major share of the overall prosthetic joint infection treatment market.

Global Analysis
North America is currently the fastest growing as well as the largest regional market for prosthetic joint infection treatment. This is mainly due to rising geriatric population, which are at an elevated risk of arthroplasty procedures. Additionally, well-established healthcare infrastructure and skilled workforce in countries like the US and Canada enable timely diagnosis and management of prosthetic joint infections. Moreover, growing public awareness about hygiene maintenance during hospital visits and joint replacement surgeries aid in region's market dominance.

However, Asia Pacific region is projected to depict the highest growth over the forecast period owing to improving access to advanced orthopedic treatments in major countries like India, China and Japan.

Get more insights on this topic : https://justpaste.it/98uch

What Are The Key Data Covered In This Prosthetic Joint Infection  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Prosthetic Joint Infection 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Prosthetic Joint Infection  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Prosthetic Joint Infection  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Prosthetic Joint Infection  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it